IMPACT OF LIMITED ORAL ANTITUBERCULOSIS INFORMATION TO THE TUBERCULOSIS PATIENTS' COMPLIANCE AND THEIR QUALITY OF LIFE

Authors

  • Dian Handayani Farmasi UAD
  • Diah Aryani Perwitasari Farmasi UAD

DOI:

https://doi.org/10.12928/pharmaciana.v3i1.423

Keywords:

drug information service, adherence, quality of life, pulmonary TB

Abstract

The study about impact of limited oral antituberculosis information delivered by
pharmacist to patient compliance and their quality of life in two public health centers in
Yogyakarta has been carried out. This study was performed using cohort event
monitoring design, with 14 pulmonary TB patients and positive Acid Resistant Basil
were treated with oral antituberculosis (OAT) for at least 1 month and were older than
15 years old. We observed the compliance of one group of patients using oral
antituberculosis who were serviced with OAT information and the other group without
OAT information service. The patients’ compliance was checked by counting the
remaining OAT and by interviewing the patients, meanwhile patient’s quality of life
were measured by SF-36 instrument. The correlation between limited OAT information
service and patient compliance were analysed using Chi Square and quality of patient’s
life were analysed using Independent t-Test with 95% confidence level. It was shown
that characteristics of patients such as age, gender, education, duration of illness, and
Directly Observed Treatment involvement did not influence patient compliance. There
was no significant correlation between limited OAT information service to patient
compliance and patients’ quality of life (P>0.05). There is no impact of limited OAT
information service to the TB patients’ compliance and their quality of life. We
suggested that the further and deeply information service delivered by pharmacists in
the public helath centers in Yogyakarta should be carried out.

Downloads

Published

2013-05-01

Issue

Vol. 3 No. 1 (2013): Pharmaciana

Section

Analytical Pharmacy and Medicinal Chemistry

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.